- Home
- NRXP vs CPIX Comparison
NRXP vs CPIX Comparison
Compare NRXP & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- CPIX
- Stock Information
- Founded
- NRXP 2015
- CPIX 1999
- Country
- NRXP United States
- CPIX United States
- Employees
- NRXP N/A
- CPIX N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- NRXP Health Care
- CPIX Health Care
- Exchange
- NRXP Nasdaq
- CPIX Nasdaq
- Market Cap
- NRXP 58.5M
- CPIX 51.5M
- IPO Year
- NRXP N/A
- CPIX 2009
- Fundamental
- Price
- NRXP $2.92
- CPIX $3.30
- Analyst Decision
- NRXP Strong Buy
- CPIX
- Analyst Count
- NRXP 5
- CPIX 0
- Target Price
- NRXP $31.40
- CPIX N/A
- AVG Volume (30 Days)
- NRXP 435.6K
- CPIX 31.2K
- Earning Date
- NRXP 11-13-2025
- CPIX 11-04-2025
- Dividend Yield
- NRXP N/A
- CPIX N/A
- EPS Growth
- NRXP N/A
- CPIX N/A
- EPS
- NRXP N/A
- CPIX N/A
- Revenue
- NRXP N/A
- CPIX $42,071,813.00
- Revenue This Year
- NRXP N/A
- CPIX N/A
- Revenue Next Year
- NRXP $395.09
- CPIX N/A
- P/E Ratio
- NRXP N/A
- CPIX N/A
- Revenue Growth
- NRXP N/A
- CPIX 11.34
- 52 Week Low
- NRXP $1.12
- CPIX $1.04
- 52 Week High
- NRXP $6.01
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- NRXP 41.65
- CPIX 47.07
- Support Level
- NRXP $3.05
- CPIX $3.41
- Resistance Level
- NRXP $3.32
- CPIX $3.54
- Average True Range (ATR)
- NRXP 0.22
- CPIX 0.19
- MACD
- NRXP -0.05
- CPIX -0.02
- Stochastic Oscillator
- NRXP 0.74
- CPIX 23.60
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.